Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs9965746 | chr18:74535895 | G/A | 6.2E-9 | 176 | 25.53 | 25.17 | 10.17 | KM Plot |
PCPG | rs9973493 | chr2:242517518 | C/T | 4.19E-11 | 178 | 25.87 | 24.85 | 10.3 | KM Plot |
PCPG | rs9975448 | chr21:34626855 | A/G | 0.000431 | 175 | 25.28 | 30.93 | 21.9 | KM Plot |
PCPG | rs9990629 | chr4:4474034 | T/C | 0.000194 | 176 | 24.85 | 25.92 | 19.22 | KM Plot |
PCPG | rs9997849 | chr4:110977053 | C/T | 0 | 178 | 26.27 | 18 | 2.93 | KM Plot |
PRAD | rs10001263 | chr4:74508 | A/G | 7.4E-6 | 494 | 31.75 | 30.8 | 30.93 | KM Plot |
PRAD | rs10027065 | chr4:72939 | T/C | 7.74E-6 | 494 | 30.8 | 30.97 | 39.23 | KM Plot |
PRAD | rs10030871 | chr4:68786 | T/C | 2.25E-9 | 491 | 30.87 | 31.13 | 33.23 | KM Plot |
PRAD | rs10040167 | chr5:7313597 | C/T | 1.19E-8 | 484 | 30.77 | 31.3 | 10.07 | KM Plot |
PRAD | rs10044736 | chr5:138320809 | A/G | 0.000141 | 494 | 29.17 | 29.63 | 32.55 | KM Plot |
PRAD | rs10046574 | chr7:135170470 | C/T | 1.88E-9 | 492 | 30.53 | 32.63 | 3.03 | KM Plot |
PRAD | rs10050631 | chr5:171764174 | C/T | 0.000137 | 494 | 27.43 | 32.43 | 31.27 | KM Plot |
PRAD | rs10062943 | chr5:137995762 | A/G | 2.8E-5 | 485 | 30.8 | 31.3 | 27.33 | KM Plot |
PRAD | rs10075255 | chr5:7327309 | G/A | 9.01E-9 | 492 | 30.8 | 31.93 | 10.07 | KM Plot |
PRAD | rs1010476 | chr1:93596936 | T/C | 1.1E-8 | 493 | 9.17 | 25.98 | 31.38 | KM Plot |